Supranormal von Willebrand factor multimers in scleroderma. 1989

P M Mannucci, and R Lombardi, and A Lattuada, and E Perticucci, and R Valsecchi, and G Remuzzi
Angelo Bianchi Bonomi Hemophilia, University of Milano, Italy.

Platelet adhesion-aggregation reactions play an early and pivotal role in the pathogenesis of systemic sclerosis in scleroderma, but the mechanisms are incompletely understood. We determined whether or not plasma from 11 consecutive patients with scleroderma contained a subset of larger than normal ("supranormal") multimers of von Willebrand factor (vWF) that are potent inducers of platelet aggregation and adhesion. Supranormal multimers were found in all patients on at least one of two different occasions 9 to 12 months apart, whatever the duration and severity of the disease, but in none of the normal controls. Administration of low-dose aspirin (40 mg) to five of the 11 patients for ten days to inhibit the platelet release reaction slightly reduced the amounts of supranormal multimers suggesting that they might originate in part from platelets. Supranormal multimers may contribute to the pathogenesis of systemic sclerosis by inducing platelet aggregation and enhancing adhesion to subendothelium under the conditions of elevated shear stress occurring in the partially occluded vessels of the arterial microcirculation of scleroderma.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008970 Molecular Weight The sum of the weight of all the atoms in a molecule. Molecular Weights,Weight, Molecular,Weights, Molecular
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001241 Aspirin The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5) Acetylsalicylic Acid,2-(Acetyloxy)benzoic Acid,Acetysal,Acylpyrin,Aloxiprimum,Colfarit,Dispril,Easprin,Ecotrin,Endosprin,Magnecyl,Micristin,Polopirin,Polopiryna,Solprin,Solupsan,Zorprin,Acid, Acetylsalicylic
D012310 Ristocetin An antibiotic mixture of two components, A and B, obtained from Nocardia lurida (or the same substance produced by any other means). It is no longer used clinically because of its toxicity. It causes platelet agglutination and blood coagulation and is used to assay those functions in vitro. Ristomycin
D012595 Scleroderma, Systemic A chronic multi-system disorder of CONNECTIVE TISSUE. It is characterized by SCLEROSIS in the SKIN, the LUNGS, the HEART, the GASTROINTESTINAL TRACT, the KIDNEYS, and the MUSCULOSKELETAL SYSTEM. Other important features include diseased small BLOOD VESSELS and AUTOANTIBODIES. The disorder is named for its most prominent feature (hard skin), and classified into subsets by the extent of skin thickening: LIMITED SCLERODERMA and DIFFUSE SCLERODERMA. Sclerosis, Systemic,Systemic Scleroderma,Systemic Sclerosis
D014841 von Willebrand Factor A high-molecular-weight plasma protein, produced by endothelial cells and megakaryocytes, that is part of the factor VIII/von Willebrand factor complex. The von Willebrand factor has receptors for collagen, platelets, and ristocetin activity as well as the immunologically distinct antigenic determinants. It functions in adhesion of platelets to collagen and hemostatic plug formation. The prolonged bleeding time in VON WILLEBRAND DISEASES is due to the deficiency of this factor. Factor VIII-Related Antigen,Factor VIIIR-Ag,Factor VIIIR-RCo,Plasma Factor VIII Complex,Ristocetin Cofactor,Ristocetin-Willebrand Factor,von Willebrand Protein,Factor VIII Related Antigen,Factor VIIIR Ag,Factor VIIIR RCo,Ristocetin Willebrand Factor

Related Publications

P M Mannucci, and R Lombardi, and A Lattuada, and E Perticucci, and R Valsecchi, and G Remuzzi
May 1989, Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia,
P M Mannucci, and R Lombardi, and A Lattuada, and E Perticucci, and R Valsecchi, and G Remuzzi
January 2017, Methods in molecular biology (Clifton, N.J.),
P M Mannucci, and R Lombardi, and A Lattuada, and E Perticucci, and R Valsecchi, and G Remuzzi
October 1988, Medical laboratory sciences,
P M Mannucci, and R Lombardi, and A Lattuada, and E Perticucci, and R Valsecchi, and G Remuzzi
February 2022, Journal of medical biochemistry,
P M Mannucci, and R Lombardi, and A Lattuada, and E Perticucci, and R Valsecchi, and G Remuzzi
January 2014, Cirugia y cirujanos,
P M Mannucci, and R Lombardi, and A Lattuada, and E Perticucci, and R Valsecchi, and G Remuzzi
January 1988, Cell,
P M Mannucci, and R Lombardi, and A Lattuada, and E Perticucci, and R Valsecchi, and G Remuzzi
January 1991, Annals of the New York Academy of Sciences,
P M Mannucci, and R Lombardi, and A Lattuada, and E Perticucci, and R Valsecchi, and G Remuzzi
July 2016, The New England journal of medicine,
P M Mannucci, and R Lombardi, and A Lattuada, and E Perticucci, and R Valsecchi, and G Remuzzi
January 2014, ASAIO journal (American Society for Artificial Internal Organs : 1992),
P M Mannucci, and R Lombardi, and A Lattuada, and E Perticucci, and R Valsecchi, and G Remuzzi
January 1986, Folia haematologica (Leipzig, Germany : 1928),
Copied contents to your clipboard!